Neuropharmagen® is a breakthrough in pharmacogenetics that helps to identify the safest and most appropriate psychotropic medication for each patient, by analyzing their DNA. It provides the most extensive genetic-based information on drug efficacy, metabolism and adverse effects.
Neuropharmagen® helps reduce the time spent searching for the most effective treatment choices unique to each patient. This allows for a faster stabilization of patients and better quality of life..

How does it work?

Neuropharmagen® testing is carried out on a saliva sample:

  • DNA markers of efficacy, optimal dosage and adverse effects are analyzed.
  • A series of specific recommendations are provided based on the test results, to help the physician choose the most appropriate choices for each patient.
Psychiatrist at Ramon y Cajal Hospital, Madrid
Deciding treatment changes in 57% of our study sample not based on a trial-and-error approach or serendipity ,but on objective supporting data from this test gives great peace of mind to the psychiatrist in his daily practice.
More info
True success stories
XVG / aged 45

XVG is 45 year-old male with a bipolar disorder who had undergone bouts of depression in recent months.
He responded unsatisfactorily with poor metabolism of Topiramate and displayed side effects as a result of treatment with Citalopram, so his psychiatrist recommended him for Neuropharmagen testing. The results of the test enabled his treatment to be changed according to his genetic profile: in this case, lithium and chlorpromazine were added to the treatment, the dosage...
More info